Mulliqi, E.; Khelwatty, S.; Bagwan, I.; Kamaludin, A.; Morgan, A.; Long, N.; Ashkan, K.; Modjtahedi, H.
The Co-Expression and Cellular Location of HER Family Members, EGFRvIII, Putative Cancer Stem Cell Biomarkers CD44 and CD109 in Patients with Glioblastoma, and Their Impacts on Prognosis. Cancers 2025, 17, 1221.
https://doi.org/10.3390/cancers17071221
AMA Style
Mulliqi E, Khelwatty S, Bagwan I, Kamaludin A, Morgan A, Long N, Ashkan K, Modjtahedi H.
The Co-Expression and Cellular Location of HER Family Members, EGFRvIII, Putative Cancer Stem Cell Biomarkers CD44 and CD109 in Patients with Glioblastoma, and Their Impacts on Prognosis. Cancers. 2025; 17(7):1221.
https://doi.org/10.3390/cancers17071221
Chicago/Turabian Style
Mulliqi, Ermira, Said Khelwatty, Izhar Bagwan, Ahmad Kamaludin, Anna Morgan, Natalie Long, Keyoumars Ashkan, and Helmout Modjtahedi.
2025. "The Co-Expression and Cellular Location of HER Family Members, EGFRvIII, Putative Cancer Stem Cell Biomarkers CD44 and CD109 in Patients with Glioblastoma, and Their Impacts on Prognosis" Cancers 17, no. 7: 1221.
https://doi.org/10.3390/cancers17071221
APA Style
Mulliqi, E., Khelwatty, S., Bagwan, I., Kamaludin, A., Morgan, A., Long, N., Ashkan, K., & Modjtahedi, H.
(2025). The Co-Expression and Cellular Location of HER Family Members, EGFRvIII, Putative Cancer Stem Cell Biomarkers CD44 and CD109 in Patients with Glioblastoma, and Their Impacts on Prognosis. Cancers, 17(7), 1221.
https://doi.org/10.3390/cancers17071221